(Q49023583)

17 February 2018

title

Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors. (English)

1 reference

17 February 2018

1 reference

Vikas Sharma

1

1 reference

17 February 2018

Suvendu Purkait

2

1 reference

17 February 2018

Sonam Takkar

3

1 reference

17 February 2018

Prit Benny Malgulwar

4

1 reference

17 February 2018

Anupam Kumar

5

1 reference

17 February 2018

Pankaj Pathak

6

1 reference

17 February 2018

Vaishali Suri

7

1 reference

17 February 2018

Mehar C Sharma

8

1 reference

17 February 2018

Ashish Suri

9

1 reference

17 February 2018

Shashank Sharad Kale

10

1 reference

17 February 2018

Ritu Kulshreshtha

11

1 reference

17 February 2018

Chitra Sarkar

12

1 reference

17 February 2018

publication date

8 January 2016

1 reference

17 February 2018

published in

Brain Tumor Pathology

1 reference

17 February 2018

volume

33

1 reference

17 February 2018

issue

2

1 reference

17 February 2018

page(s)

117-128

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s10014-015-0245-1

exact match

0 references

cites work

Emerging biomarkers in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Polycomb group proteins: navigators of lineage pathways led astray in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

EZH2 is essential for glioblastoma cancer stem cell maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Altered expression of polycomb group genes in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Extensive modulation of a set of microRNAs in primary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Identification and functional characterization of microRNAs involved in the malignant progression of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

21 January 2018

MicroRNA in Human Glioma

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Coordinated regulation of polycomb group complexes through microRNAs in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia-telangiectasia mutated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

miR-101 acts as a tumor suppressor by targeting Kruppel-like factor 6 in glioblastoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Identification and consequences of miRNA-target interactions--beyond repression of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0245-1

10.1007/S10014-015-0245-1

21 January 2018

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

26746204

1 reference

17 February 2018